Lewis sat down in an interview with NeurologyLive to discuss the presented findings
Description
At the meeting, Lewis sat down in an interview with NeurologyLive to discuss the presented findings from the trial as well as how the rapid reduction of IgG antibodies in patients with CIDP contributes to the potential effectiveness of FcRn inhibitors. He talked about the considerations that healthcare professionals should keep in mind when discussing the use of this novel treatment with patients who live with CIDP, especially in comparison with the existing available therapies. In addition, Lewis spoke about how the presence of antibodies resistant to traditional treatments might influence the global response rate of FcRn inhibitors in CIDP.
![[TIYB] Iymdhas Ymv Qqc Kvtokah](https://www.affiliateclassifiedads.com/oc-content/uploads/19693/2929981_thumbnail.webp)
You must log in or register a new account in order to contact the publisher
Useful information
- Avoid scams by acting locally or paying with PayPal
- Never pay with Western Union, Moneygram or other anonymous payment services
- Don't buy or sell outside of your country. Don't accept cashier cheques from outside your country
- This site is never involved in any transaction, and does not handle payments, shipping, guarantee transactions, provide escrow services, or offer "buyer protection" or "seller certification"